Landmark study validates Cystic Fibrosis drug for infants as young as four weeks old

In a groundbreaking revelation, a study conducted by RCSI University of Medicine and Health Sciences and Childrenâs Health Ireland has confirmed the safety and efficacy of a Cystic Fibrosis drug in newborns as young as four weeks old.